| 4.55 -0.1 (-2.15%) | 01-30 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 5.98 |
1-year : | 6.5 |
| Resists | First : | 5.12 |
Second : | 5.57 |
| Pivot price | 4.75 |
|||
| Supports | First : | 4.4 |
Second : | 3.66 |
| MAs | MA(5) : | 4.66 |
MA(20) : | 4.85 |
| MA(100) : | 5.08 |
MA(250) : | 6.81 |
|
| MACD | MACD : | -0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 20.3  |
D(3) : | 19.5 |
| RSI | RSI(14): 44.2 |
|||
| 52-week | High : | 12.94 | Low : | 3.71 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ AMWL ] has closed above bottom band by 18.6%. Bollinger Bands are 32.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.63 - 4.66 | 4.66 - 4.68 |
| Low: | 4.33 - 4.36 | 4.36 - 4.39 |
| Close: | 4.49 - 4.55 | 4.55 - 4.6 |
American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Fri, 30 Jan 2026
American Well Corporation (NYSE:AMWL) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Tue, 27 Jan 2026
Behavioral Patterns of AMWL and Institutional Flows - Stock Traders Daily
Thu, 08 Jan 2026
American Well Extends Elevance Health Digital Care Partnership - TipRanks
Wed, 07 Jan 2026
The Truth About American Well Corp (AMWL): Telehealth Bargain Or Total Bust? - AD HOC NEWS
Tue, 06 Jan 2026
American Well Corporation (NYSE:AMWL) Shares Fly 30% But Investors Aren't Buying For Growth - simplywall.st
Tue, 04 Nov 2025
Compared to Estimates, American Well (AMWL) Q3 Earnings: A Look at Key Metrics - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 15 (M) |
| Shares Float | 13 (M) |
| Held by Insiders | 5.4 (%) |
| Held by Institutions | 43.4 (%) |
| Shares Short | 141 (K) |
| Shares Short P.Month | 152 (K) |
| EPS | -7.2 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 15.61 |
| Profit Margin | -42.8 % |
| Operating Margin | -52.2 % |
| Return on Assets (ttm) | -15.2 % |
| Return on Equity (ttm) | -37.1 % |
| Qtrly Rev. Growth | -7.9 % |
| Gross Profit (p.s.) | 9.46 |
| Sales Per Share | 18 |
| EBITDA (p.s.) | -4.65 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -62 (M) |
| Levered Free Cash Flow | 6 (M) |
| PE Ratio | -0.64 |
| PEG Ratio | 0 |
| Price to Book value | 0.29 |
| Price to Sales | 0.25 |
| Price to Cash Flow | -1.08 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|